🔎 Trials Near Me

Utama › Kanser (semua jenis) › Michigan › Grand Rapids

Kajian klinikal Kanser (semua jenis) di Grand Rapids, MI

28 kajian untuk Kanser (semua jenis) sedang mencari peserta di lokasi dalam dan sekitar Grand Rapids (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)

Mengambil pesertaFasa 2
  • START Midwest ( Site 1103), Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07209111

REC-7735 in Participants With Solid Tumors

Mengambil pesertaFasa 1/2
  • START Midwest, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07819136

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

Mengambil pesertaFasa 1
  • START Midwest /ID# 279035, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07409246

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

Mengambil pesertaFasa 1/2
  • Corewell Health ( Site 4001), Grand Rapids
1 Month – 17 Years · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07630974

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

Mengambil pesertaFasa 1
  • Start Midwest, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06150157

A Study of JNJ-87890387 for Advanced Solid Tumors

Mengambil pesertaFasa 1
  • Start Midwest, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06178614

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Cancer And Hematology Centers Of Western Michigan - Grand Rapids /ID# 279955, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07365241

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Mengambil pesertaFasa 2
  • Cancer Research Consortium of West Michigan, Grand Rapids
Umur 12 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT02693535

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Mengambil pesertaFasa 1/2
  • START Midwest, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06128551

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

Mengambil pesertaFasa 1/2
  • Corewell Health ( Site 3001), Grand Rapids
1 Month – 17 Years · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06941272

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Mengambil pesertaFasa 1
  • START - Midwest Cancer Research Center, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06253871

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Mengambil pesertaFasa 3
  • The Cancer & Hematology Centers, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

Mengambil pesertaFasa 3
  • Cancer and Hematology Centers of Western Michigan, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06252649

Project: Every Child for Younger Patients With Cancer

Mengambil pesertaKajian pemerhatian
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
  • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
  • Trinity Health Grand Rapids Hospital, Grand Rapids
Sehingga umur 25 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT02402244

Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

Mengambil pesertaFasa 1/2
  • Site 04, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT07276373

A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

Mengambil pesertaFasa 1
  • START Midwest, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT06759649

A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

Mengambil pesertaFasa 1
  • START Midwest, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT06880549

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Mengambil pesertaFasa 3
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
  • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06580314

A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer

Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
  • BAMF Health Inc., Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT07258836

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • START Midwest, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT05768139

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

Mengambil pesertaFasa 1
  • GSK Investigational Site, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Jun 2026 · NCT06431594

CT-95 in Advanced Cancers Associated With Mesothelin Expression

Mengambil pesertaFasa 1
  • Context Investigational Site, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Jun 2026 · NCT06756035

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Mengambil pesertaFasa 1
  • START Midwest, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Mei 2026 · NCT07094204

A Study of YL242 in Subjects With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • US-206, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Dis 2025 · NCT07197827

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

Mengambil pesertaKajian pemerhatian
  • Corewell Health, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Jun 2025 · NCT05768269

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Mengambil peserta
  • Mercy Health Saint Mary's, Grand Rapids
  • Spectrum Health at Butterworth Campus, Grand Rapids
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Nov 2024 · NCT03860883

Kajian Kanser (semua jenis) di bandar lain

Kajian lain di Grand Rapids

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.